A Controlled Pharmacogenetic Trial of Sibutramine on Weight Loss and Body Composition in Obese or Overweight Adults
To access this article, please choose from the options below
Supported in part by National Institutes of Health grants RO1 DK 67071 and K24 DK 02638 (to M.C.); by NIH grant RR024150, which supports the Mayo Clinical Research Unit; and, for DEXA measurements, by Public Health Service grant DK50456, which funds the Minnesota Obesity Center.
Registration number of clinical trial at Clinical Trials.gov: NCT 00433641.
Conflicts of interest: The authors have no conflicts of interest to disclose.
PII: S0016-5085(08)01317-6
doi:10.1053/j.gastro.2008.07.009
© 2008 AGA Institute. Published by Elsevier Inc. All rights reserved.

